DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

Vertex Pharmaceuticals

NASDAQ: VRTX



company name or ticker
Company Photos
(Click to zoom)

Vertex Pharmaceuticals (VRTX): Today's Featured Drugs Laggard

5 Stocks Pushing The Drugs Industry Downward

What to Watch When Bristol-Myers Squibb Reports End of Year Earnings

Can Bristol-Myers put its capital to good use and push its hepatitis and oncology segments to success?

Trade-Ideas: Vertex Pharmaceuticals (VRTX) Is Today's "Barbarian At The Gate" Stock

Gilead's Sovaldi Hep C Drug Launch Strong

5 Stocks Moving The Health Care Sector Upward

Bristol-Myers Squibb Co.'s Daclatasvir May Prove a Winner

In the crowded market for treating hepatitis C, Bristol-Myers (BMY) may find a willing market for its promising drug daclatasvir.

Insider Trading Alert - VRTX, NATI, CLX, SN And IBKR Traded By Insiders

Vertex Pharmaceuticals (VRTX): Today's Featured Health Care Winner

Gilead Seeks To Expand Its Blockbuster Hepatitis Platforms In 2014

See More Articles...